1Jemal A,Bray F,Center M M,et al.Global cancer statistics [J].CA:a cancer journal for clinicians,2011,61(2):69-90. 被引量：1
2Decensi A,Costa A.Recent advances in cancer chemoprevention with emphasis on breast and cancer[J]. Eur J cancer,2002,3(6):694-709. 被引量：1
3Amedei A,Della Bella C,Silvestri E,et al.T cells in gastric cancer:friends or foes [J].Clinical and develop- mental immunology,2012,7(2): 134-144. 被引量：1
4Kume T, Oshima K,Yamashita Y,etal.Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T- lymphocyte response in lymphoepithelioma-like cancer of the stomach [J].International journal of cancer,1999,84(4): 339-343. 被引量：1
5Dunn G P,Old L J,Schreiber R D.The three Es of cancer immunoediting[J].Annu Rev Immunol,2004,22(2):329-360. 被引量：1
6Sakaguchi S,Sakaguchi N,Asano M,et al,Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].The Journal of Immunology, 1995,155 (3): 1 ] 51 - 1164. 被引量：1
7Nummer D,SuriP E,SchmitzW H,et al.Role of tumor en- dothelium in CD4+CD25 regulatory" T cell infiltration of human pancreatic carcinoma [J].Journal of the National Cancer Institute,2007,99(15): 1188-1199. 被引量：1
8Shen L S,Wang J,Shen D F,et al. CD4+CD25CDI271ow/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression[J].Clinieal Immunology,2009,131 (1): 109-118. 被引量：1
9Sasada T, Kimura M,Yoshida Y,et al.CD4+CD25regulatory T cells in patients with gastrointestinal malignancies[J]. Cance:2003,98(5): 1089-1099. 被引量：1
10Ghiringhelli F,M6nard C,Tenne M, et aI.CD4 +CD25 regulatory T cells inhibit natural killer cell functions in a transforming growth faetor-13-dependent manner[J].The Journal of experimental medieine,2005,202(8):1075-1085. 被引量：1
